Offline mode

Intended use

Enzyme immunoassay for the quantitative determination of progesterone in human saliva. For research use only. Not for use in clinical diagnostic procedures.

Test principle

Solid phase enzyme-linked immunosorbent assay (ELISA) based on the competition principle. An unknown amount of antigen present in the sample and a fixed amount of enzyme labelled antigen compete for the binding sites of the antibodies coated onto the wells. After incubation the wells are washed to stop the competition reaction. After the substrate reaction the intensity of the developed colour is inversely proportional to the amount of the antigen in the sample. Results of samples can be determined directly using the standard curve.

The new IBL International Progesterone Saliva ELISA requires as low as 50 µL Saliva sample volume and has a broad standard range up to 5,000 pg/mL.

Advantages of Standardized reagents

Our Saliva ELISA product line has been revised so that the main steroids (testosterone, progesterone, DHEA) may be processed in a similar way:

  • The substrate, washing and stop solutions are interchangeable (provided the same lot number for each component is used);
  • The enzyme conjugate, the substrate and stop solutions are uniformly pipetted with 100 µL;
  • The kits contain as few as 6 standards and 2 controls;
  • Only 50 µL sample volume is required;
  • All kits use the same sample diluent buffer.

Thanks to the similar processing and assembling, the assays can easily be performed in combination.

Pulsatile dynamics

Due to the pulsatile dynamics of steroid secretion repeated saliva sampling is recommended. IBL recommends collecting 3 to 5 saliva samples within 2 hours. In the laboratory, equal volumes of the individual saliva samples can be mixed. This mixed sample results in a mean free Progesterone value, which represents the active hormone concentration in a reproducible way.

For concrete data please consult the Instruction for Use in the download box on the top right side.

  1. Greenspan, K. (1986). Basic and clinical endocrinology. Hypoparathyroidism. Lange, 236-241.
  2. King TL, Brucker MC (25 October 2010). Pharmacology for Women's Health. Jones & Bartlett Publishers. pp. 372–373. ISBN 978-1-4496-5800-7.
  3. Gavrilova, N., & Lindau, S. T. (2009). Salivary sex hormone measurement in a national, population-based study of older adults. Journals of Gerontology Series B: Psychological Sciences and Social Sciences, 64(suppl_1), i94-i105.
  4. Jameson JL, De Groot LJ (25 February 2015). Endocrinology: Adult and Pediatric E-Book. Elsevier Health Sciences. p. 2179. ISBN 978-0-323-32195-2.
  5. Andersen, M. L., & Tufik, S. (2006). Does male sexual behavior require progesterone?. Brain research reviews, 51(1), 136-143.
  6. Oettel, M., & Mukhopadhyay, A. K. (2004). Progesterone: The forgotten hormone in men? Aging Male, 7, 236 –257
  7. Goletiani, N. V., Keith, D. R., & Gorsky, S. J. (2007). Progesterone: Review of safety for clinical studies. Experimental and clinical psychopharmacology, 15(5), 427.
  8. Bowen R (2000-08-06). "Placental Hormones". Retrieved 2020-29-12.
  9. Hall, J. E. (2004). Neuroendocrine control of the menstrual cycle. In J. F. Strauss, III, & R. L. Barbieri (Eds.), Yen and Jaffe’s reproductive endocrinology: Physiology,pathophysiology, and clinical management (5th ed., pp. 195–211). Philadelphia: Elsevier
  10. Cable, J. K., & Grider, M. H. (2020). Physiology, Progesterone. StatPearls
  11. Lu, Y. C., Bentley, G. R., Gann, P. H., Hodges, K. R., & Chatterton, R. T. (1999). Salivary estradiol and progesterone levels in conception and nonconception cycles in women: evaluation of a new assay for salivary estradiol. Fertility and sterility, 71(5), 863-868.

Our Product Families

Our comprehensive immunoassay portfolio includes a number of specialty diagnostic immunoassays for endocrinology, immunology and autoimmunity, as well as for diagnosis of multiple infectious diseases. We are pioneers and market leaders in saliva diagnostics, with over 40 years of experience supplying a broad portfolio of luminescence- and ELISA-based tests, including our highly acclaimed HMGB1 and MuSK-Ab ELISAs.

And as experts in laboratory automation, we can support our customers with the protocols for open ELISA platforms.

All products are only available for sale to laboratory professionals and may not be available in all countries. Availability and regulatory status may vary across regions depending on local country-specific registration. Please always read and follow the instructions for use. 

All of our assays have been designed and manufactured to meet the highest global regulatory requirements and quality standards. Tecan is certified under ISO 9001:2015, ISO 13485:2016 and is audited by a notified body according to Medical Device Single Audit Program (MDSAP).

Image on background

This is who we are.

As part of the Tecan Group, we have a leading market position in diagnostics and research, with over 40 years of experience in the development, manufacture and supply of enzyme-, radiolabel- and luminescence-based immunoassays.

Our range of high-quality immunoassays is supported by a diverse portfolio of automated solutions, making us the perfect partner for you and your customers.

Happy to help.

At Tecan, we are driven to improve people’s lives and health.